[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"normal-responders\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:normal-responders":30},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":36,"overallStatus":45,"whyStopped":4,"lastUpdateSubmitDate":46,"lastUpdatePostDateStruct":47,"startDateStruct":50,"completionDateStruct":52,"leadSponsor":54,"locationsCount":5},"100659219","dual-trigger-vs-hcg-trigger-for-final-oocyte-maturation-in-normal-responders-100659219",false,"NCT07861399","Dual Trigger VS HCG Trigger for Final Oocyte Maturation in Normal Responders","Dual Trigger VS HCG Trigger for Final Oocyte Maturation in Normal Responders a Randomized Controlled Trial","DT-HCG-IVF","Inclusion Criteria:\n\n* Women aged 20-40 years.\n* Body mass index (BMI) between 18 and 30 kg\u002Fm².\n* Undergoing ICSI treatment using a GnRH antagonist protocol.\n* Normal ovarian reserve and expected normal ovarian response.\n* AMH between 1.2 - 3.5 ng\u002Fml\n* AFC 7-15 follicle.\n* First or second ICSI cycle.\n\nExclusion Criteria:\n\n* Poor ovarian response (Bologna\u002FPOSEIDON criteria)\n* High ovarian response with a risk of ovarian hyperstimulation syndrome (OHSS) AMH \\> 3.5 ng\u002Fml or AFC \\> 15 follicle.\n* Polycystic ovary syndrome (PCOS).\n* Serum E2 level \\> 3500 pg\u002Fml at day of triggering.\n* Endocrine disorders including diabetes mellitus, thyroid dysfunction, hyperprolactinemia, congenital adrenal hyperplasia, or Cushing syndrome.\n* Congenital uterine abnormalities.\n* Severe systemic diseases affecting fertility outcomes.","FEMALE","20 Years","40 Years",{"count":21,"type":22},100,"ESTIMATED","INTERVENTIONAL",[25],"NA","To compare the embryological and reproductive outcomes of dual trigger versus conventional hCG trigger for final oocyte maturation in normal responder patients undergoing ICSI cycles.",[28,29,30,31,32,33,34,35],"ICSI","IVF","Normal Responders","Infertility Assisted Reproductive Technology","Infertile Women Undergoing IVF or ICSI","Infertile Women Undergoing ART","Triggering Ovulation","Oocyte Maturation",[37,38,39,40,41,42,43,44],"icsi","ivf","dual trigger","hcg trigger","infertility","ART","normal responders","oocyte maturation","RECRUITING","2026-10-05",{"date":48,"type":49},"2026-10-06","ACTUAL",{"date":51,"type":49},"2026-09-01",{"date":53,"type":22},"2028-10",{"name":55,"class":56},"Al-Azhar University","OTHER"]